The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Corneal Neovascularization

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Corneal Neovascularization


High impact information on Corneal Neovascularization


Chemical compound and disease context of Corneal Neovascularization


Biological context of Corneal Neovascularization


Anatomical context of Corneal Neovascularization


Gene context of Corneal Neovascularization


Analytical, diagnostic and therapeutic context of Corneal Neovascularization


  1. Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA. Lai, C.M., Spilsbury, K., Brankov, M., Zaknich, T., Rakoczy, P.E. Exp. Eye Res. (2002) [Pubmed]
  2. A case of rofecoxib-associated stevens-johnson syndrome with corneal and conjunctival changes. Goldberg, D., Panigrahi, D., Barazi, M., Abelson, M., Butrus, S. Cornea (2004) [Pubmed]
  3. Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor. Albert, D.H., Tapang, P., Magoc, T.J., Pease, L.J., Reuter, D.R., Wei, R.Q., Li, J., Guo, J., Bousquet, P.F., Ghoreishi-Haack, N.S., Wang, B., Bukofzer, G.T., Wang, Y.C., Stavropoulos, J.A., Hartandi, K., Niquette, A.L., Soni, N., Johnson, E.F., McCall, J.O., Bouska, J.J., Luo, Y., Donawho, C.K., Dai, Y., Marcotte, P.A., Glaser, K.B., Michaelides, M.R., Davidsen, S.K. Mol. Cancer Ther. (2006) [Pubmed]
  4. Rigid gas permeable contact lens correction of aphakia following congenital cataract removal during infancy. Amos, C.F., Lambert, S.R., Ward, M.A. Journal of pediatric ophthalmology and strabismus. (1992) [Pubmed]
  5. Control of angiogenesis with synthetic heparin substitutes. Folkman, J., Weisz, P.B., Joullié, M.M., Li, W.W., Ewing, W.R. Science (1989) [Pubmed]
  6. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Wiley, S.R., Cassiano, L., Lofton, T., Davis-Smith, T., Winkles, J.A., Lindner, V., Liu, H., Daniel, T.O., Smith, C.A., Fanslow, W.C. Immunity (2001) [Pubmed]
  7. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. Hernández, G.L., Volpert, O.V., Iñiguez, M.A., Lorenzo, E., Martínez-Martínez, S., Grau, R., Fresno, M., Redondo, J.M. J. Exp. Med. (2001) [Pubmed]
  8. gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. Cao, Y., Chen, C., Weatherbee, J.A., Tsang, M., Folkman, J. J. Exp. Med. (1995) [Pubmed]
  9. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. Lee, S., Zheng, M., Kim, B., Rouse, B.T. J. Clin. Invest. (2002) [Pubmed]
  10. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. Matsubara, T., Saura, R., Hirohata, K., Ziff, M. J. Clin. Invest. (1989) [Pubmed]
  11. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Takano, S., Gately, S., Neville, M.E., Herblin, W.F., Gross, J.L., Engelhard, H., Perricone, M., Eidsvoog, K., Brem, S. Cancer Res. (1994) [Pubmed]
  12. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Daniel, T.O., Liu, H., Morrow, J.D., Crews, B.C., Marnett, L.J. Cancer Res. (1999) [Pubmed]
  13. A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy. Carron, C.P., Meyer, D.M., Pegg, J.A., Engleman, V.W., Nickols, M.A., Settle, S.L., Westlin, W.F., Ruminski, P.G., Nickols, G.A. Cancer Res. (1998) [Pubmed]
  14. Lipid-mediated delivery of brain-specific angiogenesis inhibitor 1 gene reduces corneal neovascularization in an in vivo rabbit model. Yoon, K.C., Ahn, K.Y., Lee, J.H., Chun, B.J., Park, S.W., Seo, M.S., Park, Y.G., Kim, K.K. Gene Ther. (2005) [Pubmed]
  15. Interleukin-8. A corneal factor that induces neovascularization. Strieter, R.M., Kunkel, S.L., Elner, V.M., Martonyi, C.L., Koch, A.E., Polverini, P.J., Elner, S.G. Am. J. Pathol. (1992) [Pubmed]
  16. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization. Zhang, Z., Ma, J.X., Gao, G., Li, C., Luo, L., Zhang, M., Yang, W., Jiang, A., Kuang, W., Xu, L., Chen, J., Liu, Z. Invest. Ophthalmol. Vis. Sci. (2005) [Pubmed]
  17. Treatment of ocular tissues exposed to nitrogen mustard: beneficial effect of zinc desferrioxamine combined with steroids. Morad, Y., Banin, E., Averbukh, E., Berenshtein, E., Obolensky, A., Chevion, M. Invest. Ophthalmol. Vis. Sci. (2005) [Pubmed]
  18. Downregulation of IRS-1 expression causes inhibition of corneal angiogenesis. Berdugo, M., Andrieu-Soler, C., Doat, M., Courtois, Y., BenEzra, D., Behar-Cohen, F. Invest. Ophthalmol. Vis. Sci. (2005) [Pubmed]
  19. Rapid ocular angiogenic control via naked DNA delivery to cornea. Stechschulte, S.U., Joussen, A.M., von Recum, H.A., Poulaki, V., Moromizato, Y., Yuan, J., D'Amato, R.J., Kuo, C., Adamis, A.P. Invest. Ophthalmol. Vis. Sci. (2001) [Pubmed]
  20. Effects of 1alpha,25-dihydroxyvitamin D3 on Langerhans cell migration and corneal neovascularization in mice. Suzuki, T., Sano, Y., Kinoshita, S. Invest. Ophthalmol. Vis. Sci. (2000) [Pubmed]
  21. Effect of copper ion on collagenase release. Its implication in corneal vascularization. Lin, M.T., Chen, Y.L. Invest. Ophthalmol. Vis. Sci. (1992) [Pubmed]
  22. Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo. Singh, N., Amin, S., Richter, E., Rashid, S., Scoglietti, V., Jani, P.D., Wang, J., Kaur, R., Ambati, J., Dong, Z., Ambati, B.K. Invest. Ophthalmol. Vis. Sci. (2005) [Pubmed]
  23. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Goede, V., Brogelli, L., Ziche, M., Augustin, H.G. Int. J. Cancer (1999) [Pubmed]
  24. Suppression of corneal neovascularization by PEDF release from human amniotic membranes. Shao, C., Sima, J., Zhang, S.X., Jin, J., Reinach, P., Wang, Z., Ma, J.X. Invest. Ophthalmol. Vis. Sci. (2004) [Pubmed]
  25. Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. White, R.R., Shan, S., Rusconi, C.P., Shetty, G., Dewhirst, M.W., Kontos, C.D., Sullenger, B.A. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  26. Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. Cursiefen, C., Masli, S., Ng, T.F., Dana, M.R., Bornstein, P., Lawler, J., Streilein, J.W. Invest. Ophthalmol. Vis. Sci. (2004) [Pubmed]
  27. FasL-Fas interactions regulate neovascularization in the cornea. Stuart, P.M., Pan, F., Plambeck, S., Ferguson, T.A. Invest. Ophthalmol. Vis. Sci. (2003) [Pubmed]
  28. Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Armstrong, L.C., Bornstein, P. Matrix Biol. (2003) [Pubmed]
  29. Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. Kure, T., Chang, J.H., Kato, T., Hernández-Quintela, E., Ye, H., Lu, P.C., Matrisian, L.M., Gatinel, D., Shapiro, S., Gosheh, F., Azar, D.T., Gosheh, F. Invest. Ophthalmol. Vis. Sci. (2003) [Pubmed]
  30. Mouse strain-dependent heterogeneity of resting limbal vasculature. Chan, C.K., Pham, L.N., Chinn, C., Spee, C., Ryan, S.J., Akhurst, R.J., Hinton, D.R. Invest. Ophthalmol. Vis. Sci. (2004) [Pubmed]
  31. Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer. Ozerdem, U. Prostate (2006) [Pubmed]
  32. Ocular inflammation in patients using soft contact lenses. Rietschel, R.L., Wilson, L.A. Archives of dermatology. (1982) [Pubmed]
  33. Suppression of corneal neovascularization with cyclosporine. Lipman, R.M., Epstein, R.J., Hendricks, R.L. Arch. Ophthalmol. (1992) [Pubmed]
WikiGenes - Universities